Literature DB >> 3254936

Utilization and metabolism of NAD by Haemophilus parainfluenzae.

M H Cynamon1, T B Sorg, A Patapow.   

Abstract

The utilization of exogenous nicotinamide adenine dinucleotide (NAD) by Haemophilus parainfluenzae was studied in suspensions of whole cells using radiolabelled NAD, nicotinamide mononucleotide (NMN), and nicotinamide ribonucleoside (NR). The utilization of these compounds by H. parainfluenzae has the following characteristics. (1) NAD is not taken up intact, but rather is degraded to NMN or NR prior to internalization. (2) Uptake is carrier-mediated and energy-dependent with saturation kinetics. (3) There is specificity for the beta-configuration of the glycopyridine linkage. (4) An intact carboxamide groups is required on the pyridine ring. The intracellular metabolism of NAD was studied in crude cell extracts and in whole cells using carbonyl-14C-labelled NR, NMN, NAD, nicotinamide, and nicotinic acid as substrates in separate experiments. A synthetic pathway from NR through NMN to NAD that requires Mg2+ and ATP was demonstrated. Nicotinamide was found as an end-product of NAD degradation. Nicotinic acid mononucleotide and nicotinic acid adenine dinucleotide were not found as intermediates. The NAD synthetic pathway in H. parainfluenzae differs from the Preiss-Handler pathway and the pyridine nucleotide cycles described in other bacteria.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3254936     DOI: 10.1099/00221287-134-10-2789

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  14 in total

1.  Ribosylnicotinamide kinase domain of NadR protein: identification and implications in NAD biosynthesis.

Authors:  Oleg V Kurnasov; Boris M Polanuyer; Shubha Ananta; Roman Sloutsky; Annie Tam; Svetlana Y Gerdes; Andrei L Osterman
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

2.  Nicotinamide ribosyl uptake mutants in Haemophilus influenzae.

Authors:  Mark Herbert; Elizabeta Sauer; Graeme Smethurst; Anita Kraiss; Anna-Karina Hilpert; Joachim Reidl
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

3.  Coupling of NAD+ biosynthesis and nicotinamide ribosyl transport: characterization of NadR ribonucleotide kinase mutants of Haemophilus influenzae.

Authors:  Melisa Merdanovic; Elizabeta Sauer; Joachim Reidl
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

Review 4.  NAD+ utilization in Pasteurellaceae: simplification of a complex pathway.

Authors:  Gabriele Gerlach; Joachim Reidl
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

5.  Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence.

Authors:  P R Martin; R J Shea; M H Mulks
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

6.  NadN and e (P4) are essential for utilization of NAD and nicotinamide mononucleotide but not nicotinamide riboside in Haemophilus influenzae.

Authors:  G Kemmer; T J Reilly; J Schmidt-Brauns; G W Zlotnik; B A Green; M J Fiske; M Herbert; A Kraiss; S Schlör; A Smith; J Reidl
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

7.  Vibrio Phage KVP40 Encodes a Functional NAD+ Salvage Pathway.

Authors:  Jae Yun Lee; Zhiqun Li; Eric S Miller
Journal:  J Bacteriol       Date:  2017-04-11       Impact factor: 3.490

Review 8.  NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus.

Authors:  Carles Cantó; Keir J Menzies; Johan Auwerx
Journal:  Cell Metab       Date:  2015-06-25       Impact factor: 27.287

9.  In vitro evaluation of nicotinamide riboside analogs against Haemophilus influenzae.

Authors:  C P Godek; M H Cynamon
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

10.  From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways.

Authors:  Svetlana Y Gerdes; Michael D Scholle; Mark D'Souza; Axel Bernal; Mark V Baev; Michael Farrell; Oleg V Kurnasov; Matthew D Daugherty; Faika Mseeh; Boris M Polanuyer; John W Campbell; Shubha Anantha; Konstantin Y Shatalin; Shamim A K Chowdhury; Michael Y Fonstein; Andrei L Osterman
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.